Impact of the adjuvant management and risk factors on survival in FIGO stage 3 endometrial cancer patients

被引:0
|
作者
Ko, J. J. [1 ]
Gelowitz, G. [1 ]
Tinker, A. V. [2 ]
Holloway, C. [3 ]
Kumar, A. [4 ]
机构
[1] Abbotsford Reg Hosp & Canc Ctr, System Therapy, Abbotsford, BC, Canada
[2] BC Canc Agcy Vancouver, System Therapy, Vancouver, BC, Canada
[3] BC Canc Agcy Victoria, Radiat Oncol, Victoria, BC, Canada
[4] Fraser Valley Canc Ctr, Syst Therapy, Surrey, BC, Canada
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
976P
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Is there a survival benefit to adjuvant radiotherapy in high-risk surgical stage I endometrial cancer?
    Ayhan, A
    Taskiran, C
    Celik, C
    Guney, I
    Yuce, K
    Ozyar, E
    Atahan, L
    Kucukali, T
    GYNECOLOGIC ONCOLOGY, 2002, 86 (03) : 259 - 263
  • [42] Quantifying the risk of recurrence and death in stage III (FIGO 2009) endometrial cancer
    Milgrom, Sarah A.
    Kollmeier, Marisa A.
    Abu-Rustum, Nadeem R.
    O'Cearbhaill, Roisin E.
    Barakat, Richard R.
    Alektiar, Kaled M.
    GYNECOLOGIC ONCOLOGY, 2014, 134 (02) : 297 - 301
  • [43] Quantifying the Risk of Recurrence and Death in Stage III (FIGO 2009) Endometrial Cancer
    Milgrom, S. A.
    Kollmeier, M. A.
    Abu-Rustum, N. R.
    O'Cearbhaill, R. E.
    Barakat, R. R.
    Alektiar, K. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S128 - S128
  • [44] Overall survival in patients with FIGO stage IVA cervical cancer
    Schiff, Joshua P.
    Mintz, Rachel
    Cohen, Alexander C.
    Huang, Yi
    Thaker, Premal
    Massad, Leslie S.
    Powell, Matthew
    Mutch, David
    Schwarz, Julie K.
    Markovina, Stephanie T.
    Grigsby, Perry W.
    GYNECOLOGIC ONCOLOGY, 2022, 166 (02) : 292 - 299
  • [45] Rethinking for Pathological Risk Factors of Patients With FIGO Stage I and II Cervical Cancer
    Zhang, Y.
    Li, J.
    Wei, L.
    Shi, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S470 - S470
  • [46] Predictors of Survival in Patients With FIGO Stage IVB Cervical Cancer
    Sasano, Tomoyuki
    Mabuchi, Seiji
    Kuroda, Hiromasa
    Takahashi, Ryoko
    Kozasa, Katsumi
    Isohashi, Fumiaki
    Yoshioka, Yasuo
    Ogawa, Kazuhiko
    Kimura, Tadashi
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 (03) : 528 - 533
  • [47] Prognostic factors predicting survival in patients with FIGO stage IB cervical cancer treated surgically
    Lee, J. M.
    Lee, K. B. M.
    Park, C. Y.
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2006, 94 (02) : 143 - 144
  • [48] Adjuvant chemotherapy and radiation for patients with high-risk stage I endometrial cancer (EC) treated with curative intent surgery: the impact on recurrence and survival
    Findley, Rachelle
    Kooy, Joni
    Lester, Beverly
    Le, Nhu
    Bowering, Gale
    Rugayan, Christie
    Kumar, Aalok
    Glaze, Sarah
    Ko, Jenny
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S35 - S36
  • [49] Use of Adjuvant Therapy in Patients with FIGO Stage III Endometrial Carcinoma: A Multicenter Retrospective Study
    Marchetti, Claudia
    Pisano, Carmela
    Mangili, Giorgia
    Lorusso, Domenica
    Panici, Pierluigi Benedetti
    Silvestro, Giustino
    Candiani, Massimo
    Greggi, Stefano
    Perniola, Giorgia
    Di Maio, Massimo
    Pignata, Sandro
    ONCOLOGY, 2011, 81 (02) : 104 - 112
  • [50] Oncologic outcomes of adjuvant chemotherapy in patients with risk factors after radical surgery in FIGO stage IB-IIA cervical cancer
    Lee, K. B.
    Lee, J. M.
    Kim, Y. S.
    GYNECOLOGIC ONCOLOGY, 2017, 145 : 8 - 10